专利名称 | METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY | ||
申请号 | WOUS19042817 | 申请日 | |
公开(公告)号 | WO2020023382A1 | 公开(公告)日 | |
申请(专利权)人 | ELI LILLY AND COMPANY | 发明人 | BENSON Charles T; HAUPT Axel; THOMAS Melissa Kay; URVA Shweta |
专利来源 | 国家知识产权局 | 转化方式 | |
摘要 |
The present invention provides a method for increasing glycemic control in a patient in need thereof, by administering tirzepatide, or a pharmaceutically acceptable salt thereof. The present invention provides a method for improving weight management in a patient in need thereof, by administering tirzepatide, or a pharmaceutically acceptable salt thereof. Further providing a method for treating a condition selected from atherosclerosis, chronic kidney disease, NAFLD, and NASH. Further provided is a method to prevent or induce remission of diabetes comprising administration of tirzepatide, or a pharmaceutically acceptable salt thereof. Further provided is a dosing regimen for increasing glycemic control, improving weight management, and/or treating dyslipidemia. |
主管部门:海南中小企业服务 | 建设单位:海南商业联合会
版权所有:海南商业联合会 | 备案号:粤ICP备13083911号(ICP加挂服务)@2017